Pfizer Inc. CEO Albert Bourla said he doesn’t worry about political pressure to bring potentially the first coronavirus vaccine to market, but can’t escape feeling the weight of the world on his shoulders. Bourla’s company is among the leaders in developing a vaccine that could ease the strain of the global pandemic that has caused … Continue reading “Pfizer’s Bourla: There’s Coronavirus Vaccine Pressure, But It’s Not Political”
Author: Derrick Gingery
Derrick Gingery is a senior writer for the Pink Sheet.
Drug Review Times Not Shortened Much by Single Expedited Review Designation
Expedited programs usually shorten a US Food and Drug Administration new drug application assessment, but on average, maybe not as much as their reputation would suggest. A Government Accountability Office (GAO) analysis found that expedited assessment programs generally are significant variables affecting assessment times, but less so than perhaps stakeholders might expect. When all else is equal, … Continue reading “Drug Review Times Not Shortened Much by Single Expedited Review Designation”